Novel Lipoprotein (a) Therapies: A Comprehensive Review

Curr Atheroscler Rep. 2026 Aug 13;28(1):81. doi: 10.1007/s11883-026-01453-9.ABSTRACTPURPOSE OF REVIEW: Lipoprotein(a) [Lp(a)] is a genetically determined, independent risk factor for atherosclerotic cardiovascular disease and calcific aortic valve stenosis. Plasma Lp(a) levels are 70-90% heritable,

U Ugochukwu Ebubechukwu

Exercise and Cardiovascular Risk Modulation in Post-COVID Syndrome

Curr Atheroscler Rep. 2026 Aug 13;28(1):80. doi: 10.1007/s11883-026-01450-y.ABSTRACTPURPOSE OF REVIEW: Post-COVID syndrome (PASC) has emerged as a multisystem condition associated with persistent cardiovascular abnormalities, including endothelial dysfunction, arterial stiffness, chronic inflammatio

C Cássia da Luz Goulart

Senolytics Reverse PM2.5 - Induced Cell and Vascular Dysfunction

Exposure to fine airborne particulate matter (PM(2.5)) is associated with cardiovascular disease and increased atherogenesis. While some prior studies provided mechanistic insights linking exposure to lesion progression, instability, and rupture, a complete definition of cellular events contributing

D Daniel Gomes